Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Alzheimer's
Alzheimer's
Page 5 of 8
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By
Sy Mukherjee
June 7, 2021
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By
Sy Mukherjee
May 25, 2021
Newsletters
A week about Alzheimer’s drug development
By
Sy Mukherjee
March 18, 2021
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By
Sy Mukherjee
February 28, 2020
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By
Sy Mukherjee
December 5, 2019
Newsletters
Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By
Sy Mukherjee
December 2, 2019
Newsletters
Bill Gates Commits $10 Million More for Alzheimer’s Research to ‘Part the Cloud’
By
Sy Mukherjee
November 5, 2019
Newsletters
Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By
Sy Mukherjee
October 23, 2019
Health
Roche Reports Another Failure in Big Pharma’s Search for Alzheimer’s Treatment
By
Lucas Laursen
January 30, 2019
Health
A New Blood Test Could Detect Alzheimers 10 Years Earlier
By
Emily Price
January 21, 2019
Magazine
The Power of a Joint Venture
By
Clifton Leaf
January 18, 2019
Could This Radical New Approach to Alzheimer’s Lead to a Breakthrough?
By
Rick Tetzeli
January 18, 2019
Magazine
Alzheimer’s: A Trail of Disappointment for Big Pharma
By
Sy Mukherjee
January 18, 2019
Health
Is an Alzheimer’s Vaccine Possible? This Woman Thinks So
By
Sy Mukherjee
October 3, 2018
CDC: Alzheimer’s, Dementia Rate To Double By 2060
By
Brittany Shoot
September 20, 2018
Most Popular
Politics
The White House has faced a flurry of rejections after inviting 9 universities to be the first signatories of its...
By
Collin Binkley
,
Jonathan Mattise
, and others
Economy
S&P analysis of 9,000 companies worldwide finds the real cost of tariffs and other corporate costs: $1.2 trillion
By
Nino Paoli
Success
CEO of $8 billion AI company says it’s ‘mind-boggling’ that people think you can work 38 hours a week, have work-life...
By
Emma Burleigh